Massachusetts Medical Society, New England Journal of Medicine, 15(374), p. 1496-1498
DOI: 10.1056/nejmc1507131
Full text: Download
On protein and peptide assays, there was no significant between-group difference in levels of antibodies against KIR4.1 protein in serum samples obtained from 141 patients with multiple sclerosis and 131 controls.